CHDI Foundation
| Founded | 2002 |
|---|---|
| Merger of | Renewable Foundation, Inc., Sweetfeet Foundation, Inc. |
| Type | 501(c)(3) Non-operating private foundation |
| 73-1683871 | |
| Focus | Huntington's disease research and drug development |
| Location | |
| Method | Contract-based support of third-party research organizations |
| Kenneth J. Slutsky | |
| Revenue | $224,410,566 (2014) |
| Expenses | $169,211,469 (2014) |
| Website | chdifoundation |
Formerly called | High Q Foundation |
The CHDI Foundation, Inc., is a United States–based non-profit biomedical foundation that aims to "rapidly discover and develop drugs that delay or slow the progression of Huntington's disease", a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline.